PMC:7105343 / 2012-2192
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T15 | 89-108 | Disease | denotes | auto-immune disease | http://purl.obolibrary.org/obo/MONDO_0007179 |
| T16 | 94-108 | Disease | denotes | immune disease | http://purl.obolibrary.org/obo/MONDO_0005046 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T32 | 56-61 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T33 | 72-84 | Chemical | denotes | methotrexate | http://purl.obolibrary.org/obo/CHEBI_44185|http://purl.obolibrary.org/obo/CHEBI_50681 |
| T35 | 110-116 | Chemical | denotes | NSAIDs | http://purl.obolibrary.org/obo/CHEBI_35475 |
| T36 | 129-139 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 122-142 | http://purl.obolibrary.org/obo/GO_0033673 | denotes | kinase inhibitors or |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T18 | 0-180 | Sentence | denotes | There is no definitive evidence that specific cytotoxic drugs, low-dose methotrexate for auto-immune disease, NSAIDs, JAK kinase inhibitors or anti-TNFα agents are contraindicated. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T3 | 89-108 | Phenotype | denotes | auto-immune disease | http://purl.obolibrary.org/obo/HP_0002960 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 72 | 148-152 | Gene | denotes | TNFα | Gene:7124 |
| 78 | 72-84 | Chemical | denotes | methotrexate | MESH:D008727 |
| 82 | 89-108 | Disease | denotes | auto-immune disease | MESH:C538437 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T44 | 46-55 | CHEBI:4056;CHEBI:4056 | denotes | cytotoxic |
| T45 | 56-61 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
| T46 | 72-84 | CHEBI:44185;CHEBI:44185 | denotes | methotrexate |
| T47 | 94-100 | UBERON:0002405 | denotes | immune |
| T48 | 110-116 | CHEBI:35472;CHEBI:35472 | denotes | NSAIDs |
| T49 | 129-139 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T50 | 153-159 | CHEBI:38867;CHEBI:38867 | denotes | agents |
| T116 | 87-92 | SP_6;NCBITaxon:9606 | denotes | r aut |
| T41725 | 46-55 | CHEBI:4056;CHEBI:4056 | denotes | cytotoxic |
| T57030 | 56-61 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
| T16716 | 72-84 | CHEBI:44185;CHEBI:44185 | denotes | methotrexate |
| T18055 | 94-100 | UBERON:0002405 | denotes | immune |
| T51364 | 110-116 | CHEBI:35472;CHEBI:35472 | denotes | NSAIDs |
| T44173 | 129-139 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T5940 | 153-159 | CHEBI:38867;CHEBI:38867 | denotes | agents |